Jingwei Sun

2.9k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Jingwei Sun is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jingwei Sun has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jingwei Sun's work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (4 papers). Jingwei Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (4 papers). Jingwei Sun collaborates with scholars based in China, United States and Croatia. Jingwei Sun's co-authors include Jun Wang, Lieping Chen, Dallas B. Flies, Xue Han, Miguel F. Sanmamed, Linghua Zheng, Jessica Ye, Tomoe Higuchi, Lu Qiao and Agedi Boto and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Cancer Research.

In The Last Decade

Jingwei Sun

16 papers receiving 1.3k citations

Hit Papers

Siglec-15 as an immune suppressor and potential target fo... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingwei Sun China 11 753 717 438 193 109 22 1.3k
Federico Sandoval France 9 594 0.8× 777 1.1× 306 0.7× 179 0.9× 147 1.3× 16 1.1k
Kristian M. Hargadon United States 13 730 1.0× 913 1.3× 382 0.9× 185 1.0× 125 1.1× 28 1.4k
Nana-Ama A.S. Anang United States 4 762 1.0× 973 1.4× 223 0.5× 162 0.8× 76 0.7× 6 1.2k
Iván Martínez‐Forero Spain 20 909 1.2× 825 1.2× 297 0.7× 104 0.5× 112 1.0× 29 1.4k
Ilenia Pellicciotta United States 14 666 0.9× 742 1.0× 313 0.7× 190 1.0× 94 0.9× 24 1.2k
Justin D. Saco United States 4 792 1.1× 966 1.3× 368 0.8× 216 1.1× 142 1.3× 5 1.4k
Anna Kwilas United States 16 457 0.6× 587 0.8× 240 0.5× 246 1.3× 106 1.0× 24 969
Amandine Alard United States 10 724 1.0× 851 1.2× 576 1.3× 315 1.6× 169 1.6× 13 1.6k
Shuhua Wei China 12 559 0.7× 443 0.6× 347 0.8× 195 1.0× 157 1.4× 21 1.1k
Maria Libera Ascierto United States 19 577 0.8× 677 0.9× 397 0.9× 188 1.0× 181 1.7× 44 1.2k

Countries citing papers authored by Jingwei Sun

Since Specialization
Citations

This map shows the geographic impact of Jingwei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwei Sun more than expected).

Fields of papers citing papers by Jingwei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwei Sun. The network helps show where Jingwei Sun may publish in the future.

Co-authorship network of co-authors of Jingwei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwei Sun. A scholar is included among the top collaborators of Jingwei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwei Sun. Jingwei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhen, et al.. (2025). First Identification of a Novel HIV-1 CRF80_0107/B Recombinant Form Among Men Who Have Sex with Men in Hebei Province, China. AIDS Research and Human Retroviruses. 42(1). 38–43.
2.
Gao, Yang, Xu He, Fan Gao, et al.. (2025). Neutrophil extracellular trap-related signature predicts the prognosis and immunotherapy outcome of lung adenocarcinoma. Genomics. 117(6). 111147–111147.
3.
Chen, Xiaohong, Jiahui Jin, Sheng Yao, et al.. (2025). Engineering DNA Origami Captors for TGFβ1 Sequestration to Enhance Tumor Immune Modulation and Therapy. Advanced Science. 12(37). e06827–e06827.
4.
Sun, Jingwei, Minjie Zheng, Jian-An Xian, et al.. (2024). Research on Rehabilitation Exercise Guidance System based on Action Quality Assessment. 1–5.
5.
Liu, Yanbin, Zhenjiang Liu, Yixiao Yang, et al.. (2023). The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer. British Journal of Cancer. 129(7). 1041–1049. 17 indexed citations
6.
Feng, Hao, Ling Qiu, Zixiao Shi, et al.. (2022). Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy. Cancer Medicine. 12(3). 3313–3327. 10 indexed citations
7.
He, Lili, Jingwei Sun, Wei-Cheng Chen, et al.. (2022). CpG site hypomethylation at ETS1‑binding region regulates DLK1 expression in Chinese patients with Tetralogy of Fallot. Molecular Medicine Reports. 25(3). 3 indexed citations
8.
Wang, Shuhang, Jingwei Sun, Kun Chen, et al.. (2021). Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors. BMC Medicine. 19(1). 140–140. 150 indexed citations
10.
Sun, Jingwei, Lu Qiao, Miguel F. Sanmamed, & Jun Wang. (2020). Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy. Clinical Cancer Research. 27(3). 680–688. 107 indexed citations
11.
Sun, Jingwei, et al.. (2020). The toxicity of cell therapy: Mechanism, manifestations, and challenges. Journal of Applied Toxicology. 41(5). 659–667. 9 indexed citations
12.
Wang, Jun, Jingwei Sun, Linda N. Liu, et al.. (2019). Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nature Medicine. 25(4). 656–666. 488 indexed citations breakdown →
13.
Wang, Jun, Ruirong Yuan, Wenru Song, et al.. (2017). PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective. Journal of Hematology & Oncology. 10(1). 34–34. 82 indexed citations
14.
Zhu, Yuwen, Sheng Yao, Mathew M. Augustine, et al.. (2016). Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM. Science Advances. 2(4). e1500637–e1500637. 38 indexed citations
15.
Flies, Dallas B., Xue Han, Tomoe Higuchi, et al.. (2014). Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity. Journal of Clinical Investigation. 124(5). 1966–1975. 237 indexed citations
16.
Mao, Haiting, Yuhong Yang, Yujing Bi, et al.. (2010). New Insights of CTLA-4 into Its Biological Function in Breast Cancer. Current Cancer Drug Targets. 10(7). 728–736. 83 indexed citations
17.
Zhao, Yanping, Renchi Yang, Jiali Wu, et al.. (2010). The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A. Haemophilia. 16(4). 632–639. 28 indexed citations
18.
Yu, Yuanhua, et al.. (2009). Seroepidemiology and genetic characterization of hepatitis E virus in the northeast of china. Infection Genetics and Evolution. 9(4). 554–561. 47 indexed citations
19.
Sun, Jingwei, Jing Yang, Jianping Zhang, & Yonghong Yan. (2009). Chinese Prosody Structure Prediction Based on Conditional Random Fields. 602–606. 1 indexed citations
20.
Sun, Jingwei, et al.. (2009). A polynomial segment model based statistical parametric speech synthesis sytem. 4021–4024. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026